Market Overview

Cancer Genetics (NASDAQ: CGIX)

0.14 -0.02 (-14.45%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/03/18Maxim GroupDowngradesHold
12/07/17Maxim GroupInitiates Coverage OnBuy6.0
6/27/17Dawson JamesInitiates Coverage OnBuy
6/26/17BenchmarkInitiates Coverage OnSpeculative Buy6.0
9/26/16Rodman & RenshawInitiates Coverage onBuy6.0
3/15/16Aegis CapitalMaintainsBuy8.0
3/11/16Janney CapitalDowngradesNeutral
4/09/15Janney CapitalInitiates Coverage onBuy13.0
8/15/14Cantor FitzgeraldMaintainsBuy15.0
4/01/14Cantor FitzgeraldInitiates Coverage onBuy21.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter